Talus Bioscience
Talus Bioscience develops AI models and native-cell proteomics technology for drug discovery. Its Ptarmigan-1 model predicts how small molecules engage proteins without requiring a 3D structure, while MARMOT measures protein interactions and changes in living human cells, enabling researchers to investigate hard-to-drug targets such as disordered proteins and transcription factors.
Facts
- HQ
- Seattle, Washington
- Sectors
- Biotechnology Research
- Founded
- 2020
- Type
- Corporation Seattle business license
- Employees
- 24
- Registered name
- Talus Bioscience Inc Seattle business license
- Stage
- Seed
- Members see funding amounts. .
- Founders
- Alex Federation, Lindsay Pino
Is this your organization? Claim it
Talus Bioscience launches Ptarmigan-1, structure-free AI that predicts binding sites across human proteome
Talus Bioscience has launched Ptarmigan-1, a structure-free AI model that predicts small-molecule binding sites across the entire human proteome, including highly unstructured proteins. The model, built on Talus’s MARMOT platform, is accessible now via a public portal.
Milad Alucozai spotlights Talus Bio's Ptarmigan-1: a 256-dimensional lookup model that screens trillions of compounds across the regulome and outperforms docking on STAT6 and KRAS G12C
Milad Alucozai describes Talus Bio's Ptarmigan-1, a model that maps proteins and small molecules into a shared 256-dimensional space to enable very fast, large-scale virtual screening across the human regulome without relying on static structures, and reports strong validation on STAT6 and KRAS G12C that suggest the model learned biological signals rather than memorizing data.
Plug and Play Seattle selects 11 startups for 12-week Batch 4, including Tokyo’s Aeterlink; demo day Dec. 3
Plug and Play Seattle selected 11 startups for its fourth 12-week accelerator cohort—10 from Seattle and one from Tokyo—working on technologies from space robotics and data-center optical links to wireless power and antibody therapeutics, with the program running through mid-December and a demo day on Dec. 3 at the Boeing Future of Flight.
By Talus Bioscience
See all 11Talus Bio and PRISM BioLab partner to discover first-in-class small‑molecule modulators of transcription factors and PPIs using AI and PepMetics® chemistry
Talus Bio and PRISM BioLab have launched a strategic collaboration combining PRISM’s PepMetics® chemistry with Talus’s AI-guided regulome profiling to discover and optimize small-molecule modulators of transcription factors and protein–protein interactions that have resisted conventional approaches.
Talus Bio presents preclinical data showing TAL61 antitumor activity and platform validation across Brachyury, NONO, and AR‑V7 targets
Talus Bio reported preclinical data showing its regulome sequencing platform can generate drug candidates against transcription factors, with TAL61 showing anti-tumor activity in chordoma and Brachyury-positive NSCLC and additional promising compounds for NONO and AR-V7 in prostate cancer.
Talus Bio names Chris Joyce, MBA as VP of Business Development to drive pharma deals and advance TF therapeutics
Talus Bio hired Chris Joyce, MBA as VP of Business Development to accelerate pharma partnerships and advance its transcription factor therapeutics, including two programs targeting TBXT for non-small cell lung cancer and NONO-related androgen receptor splicing in castration-resistant prostate cancer.
People
-
Alex Federation Executive Officer, Director, Promoter, Chief Executive Officer & Co-Founder
-
Lindsay Pino Executive Officer, Director, Chief Technology Officer & Co-Founder
-
Michelle Briscoe Executive, Executive Officer, Chief Operating Officer & Chief Financial Officer
Online
Questions about Talus Bioscience
What is Talus Bioscience?
talus.bio
Who are the people behind Talus Bioscience?
Seattle Flow lists Alex Federation (Executive Officer, Director, Promoter, Chief Executive Officer & Co-Founder), Lindsay Pino (Executive Officer, Director, Chief Technology Officer & Co-Founder) and Michelle Briscoe (Executive, Executive Officer, Chief Operating Officer & Chief Financial Officer) at Talus Bioscience.
Who invested in Talus Bioscience, and how much has it raised?
Members of Seattle Flow see Talus Bioscience's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Talus Bioscience based?
Talus Bioscience is headquartered in Seattle, Washington.
When was Talus Bioscience founded?
Talus Bioscience was founded in 2020.
How many people work at Talus Bioscience?
Talus Bioscience has 24 employees.